Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and

Kazuhiro Shindo1, Hiroki Fukuda1, Tatsuro Hitsumoto1

  • 1Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shinmachi, Suita, Osaka, Japan.

Insights

High plasma BNP levels predict cardiovascular events like heart failure and myocardial infarction in patients with impaired glucose tolerance. Diuretic use also predicts these events but not coronary stenosis progression.

Area of Science:

  • Cardiology
  • Endocrinology
  • Medical Informatics

Background:

  • Impaired glucose tolerance (IGT) is a risk factor for cardiovascular events.
  • Alpha-glucosidase inhibitors did not prevent cardiovascular events in patients with myocardial infarction (MI) and IGT in the ABC study.
  • Identifying clinical factors for cardiovascular events in MI patients with IGT is crucial.

Purpose of the Study:

  • To identify clinical factors predicting cardiovascular events in patients with myocardial infarction (MI) and impaired glucose tolerance (IGT).

Main Methods:

  • Utilized an artificial intelligence (AI)-based data mining method, the limitless-arity multiple testing procedure.
  • Analyzed 385,391 combinations of fewer than four clinical parameters in 853 patients.
  • Verified findings using Kaplan-Meier curves.

Main Results:

  • Identified 380 predictive combinations for hospitalization (all-cause, heart failure, non-fatal MI) and revascularization (PCI/CABG).
  • Plasma BNP levels ≥ 200 pg/dl or diuretic use predicted all-cause hospitalization, worsening heart failure, and non-fatal MI.
  • Plasma BNP levels ≥ 200 pg/dl uniquely predicted hospitalization for PCI/CABG, indicating a role in coronary stenosis progression.

Conclusions:

  • High plasma BNP levels predict coronary stenosis, recurrent MI, and worsening heart failure in MI patients with IGT.
  • Diuretic use predicts non-fatal MI and worsening heart failure but not coronary stenosis progression.
  • Plasma BNP levels are a key predictor of adverse cardiovascular outcomes and need for revascularization in this patient group.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
472
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
491
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
741
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.1K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
301
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
707